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Objectives: excessive deposition of extracellular matrix (ECM) proteins plays a key role in the intervention-related
vascular fibroproliferative response, resulting in intimal hyperplasia (IH). Cytokines, such as Platelet-derived growth
factor (PDGF), released after vascular injury and deposited in the ECM, are known to stimulate production of matrix
proteins. Photodynamic therapy (PDT), the combination of light and a photosensitive dye to produce free radicals, is a
novel approach to inhibit experimental IH by the local eradication of smooth-muscle cells (SMC) and alteration of ECM.
This in vitro study examined whether PDT can inhibit the fibrotic response of vascular SMC.
Materials and methods: the effect of PDT on important pro-fibrotic factors was determined by performing PDT of
isolated ECM, injured SMC and pure PDGF. SMC production of collagen was monitored by cellular [3H]-proline
incorporation.
Results: untreated SMC seeded on ECM demonstrated an increase of 50% in collagen production (p<0.0001) as compared
to SMC on an empty plate. This increase was also seen when SMC was incubated with the conditioned media of
mechanically injured SMC, or pure PDGF. However, after PDT of ECM, injured SMC or PDGF, there was an inhibition
of 40% (p<0.05) in SMC-collagen production.
Conclusions: these findings indicate that PDT can interfere with factors that lead to the vascular fibrotic response. In
this way, PDT, with its cytotoxic and extracellular effects, can promote healing of the vessel wall without the stimulus
of fibrosis that can lead to restenosis.
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Introduction is believed to significantly contribute to the de-
velopment of restenosis.3
Numerous mechanical and pharmacological ap-Restenosis limits the long-term patency of catheter-
proaches have been used to inhibit the occurrence ofbased and surgical procedures for the treatment of
IH; however, none of them has been proven clinicallyatherosclerotic occlusive disease.1 Histopathological
successful in preventing the development of re-studies in both animals and humans suggest that
stenosis.1 Among several novel experimental in-intimal hyperplasia (IH) plays an important role in
vestigations, such as gene-therapy and ionizingrestenosis development. IH is a local fibrotic lesion
irradiation,1 photodynamic therapy (PDT) has gainedthat develops in response to vascular wall injury.
interest as an approach to inhibit injury-induced IH.4–7Sustained production and deposition of extracellular
PDT is a local treatment modality based on the ac-matrix (ECM) components, such as collagen, by intimal
tivation of a photosensitive dye by a wavelength-SMC are prominent features of restenosis. This con-
specific light to generate cytotoxic free radicals. Tonective tissue mass forms the bulk of the intimal lesion
perform PDT of the vascular wall, a photosensitiser isencroaching on the vessel lumen.1,2 In response to the
administered and the area of interest irradiated withgrowing luminal mass, the vessel wall is able to enlarge
light. Inhibition of IH by PDT in balloon-injury modelsits size to compensate for the luminal narrowing.
has been related to depletion of medial SMC at theFailure of this compensatory remodelling mechanism
PDT-treatment site.4–7 However, recent in vitro studies
have shown that PDT-mediated changes in the ECM8
and its interaction with biologically active proteins9–11
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The SMC fibroproliferative response following vas- 1.0·105 on twelve-well plates and grown to confluence
for seven days. The cell monolayer was removedcular injury is to a great extent mediated by the release
and activation of cytokines from adhering platelets by incubation with a phosphate-buffered saline (PBS)
solution containing 0.5% Triton X-100 (Sigma Chemicaland damaged vascular cells. Subsequent deposition
of fibroproliferative factors, such as platelet-derived Company, St Louis, MO, U.S.A.) and 20 mmol/l
NH4OH for 30 minutes. After rinsing ·3 with PBS,growth factor (PDGF), in the surrounding ECM is
believed to play an important role in the sustained the resultant ECM coating the cell-culture plates was
covered with 1 ml PBS and used immediately forstimulation of cells for matrix production.1,2 In an in
vitro model, this study addressed how the PDT-treated experiments.
artery, now devoid of cells and with altered arterial
matrix from the treatment, would affect the non-PDT Photodynamic therapy
treated cells from the adjoining tissue and artery wall.
Would the cells that repopulate or exist adjacent to PDT was performed on isolated ECM, SMC in culture,
this PDT-treated artery develop a significant fibrotic and pure PDGF. Careful measures were taken to mini-
reaction? To examine whether PDT could interfere mise ambient-light exposure of the preparations in all
with the fibrotic response associated with vascular experiments. To conduct PDT of ECM, the matrix-
injury, this study investigated the effects of PDT on coated plates were covered with the photosensitiser
important mediators of the fibrotic process. To ac- chloroaluminium sulphonated phthalocyanine (CA-
complish this, the production of collagen by SMC SPc) diluted in PBS (5 lg/ml) and irradiated with an
was monitored after PDT-treatment of isolated ECM, argon-pumped dye laser using in vivo relevant light
injured SMC in culture and the pro-fibrotic mediator parameters (Coherent Innova I and Coherent CR 599,
PDGF. Coherent, Palo Alto, CA, U.S.A.) (wavelength: 675 nm;
irradiance: 100 mW/cm2; fluence: 10 and 100 J/cm2) as
Materials and Methods described before.8 Controls included plates without
ECM, non-treated ECM, laser-only irradiated or drug-Cell culture
only exposed ECM.
To perform PDT of SMC, 2.5·105 cells were seededPrimary bovine aortic SMC and endothelial-cell (EC)
cultures were obtained from aortas of slaughtered on 6-well plates. After a 24-hour incubation time the
medium was removed and the cells were incubatedcalves. ECs were obtained by scraping the intimal
aortic surface and dispersion in 0.1% CLS II collagenase for two hours with either PBS or CASPc (5 lm/ml).
The cells were then irradiated as described above(Worthington; Freehold, NJ, U.S.A.). The EC identity
was confirmed by the polygonal, monolayer shape with fluences of 10 and 100 J/cm2. Using these PDT-
parameters, there was negligible cell survival afterseen on phase-contrast microscopy and by uptake of
the fluorescent probe Di-I-Ac-LDL (Biomedical Re- both 10 and 100 J/cm2 as determined by the MTT-
assay (data not shown).11 However, immediately aftersearch Technologies, Inc., Stoughton, MA, U.S.A.).
SMC cultures were established with the explant tech- PDT-treatment the cells looked microscopically intact
and there was no detachment of the cells from thenique from strips of aortic media. Their identity was
verified by indirect immunofluorescence with an anti- plate.11 After PDT-treatment, the CASPc was removed
and the cells were incubated in serum-free 0.1% bovinea actin antibody (Biomedical Research Technologies,
Inc., Stoughton, MA, U.S.A.). Both cell types were kept serum albumin (BSA) medium for preparation of con-
ditioned media.in a 37 °C incubator in a concentration of 5% CO2.
Cells were fed every 72 hours with complte Dulbecco’s To perform PDT on pure PDGF, a solution of CASPc
(5 lg/ml), 5 ng/ml of PDGF-BB (Gibco) and 0.1% BSAmodified Eagles media supplemented with 10% calf
serum, 100 U/ml penicillin, 100 lg/ml streptomycin, was prepared. One ml of this solution was placed on
12-well plates and irradiated as above with fluencesand 0.6 mol/l L-glutamine (Gibco, Grand Island, NY,
U.S.A.). Cells were passed using 0.05% trypsin (Gibco) of 10 and 100 J/cm2. The solution with CASPc only
served as baseline control and non-irradiated CASPc-and subcultures from passages 2 through 4 were used
for experiments, which were performed in triplicate. PDGF solution as positive control.
Preparation of ECM Preparation of conditioned media
EC-derived ECM was prepared as previously de- These experiments were performed to examine
whether PDT of SMC could interfere with fibro-pro-scribed.8 In brief, the cells were seeded at a density of
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Fig. 1. Contrast photomicrograph of vascular SMC seeded on untreated ECM (left) and PDT-treated ECM (right). The pictures were made
24 hours after seeding to allow for proper attachment and organisation of the cells. Note that there is no difference in the morphologic
appearance between the SMC on the two different matrices. Bar equals 10 lm
liferative factors released after cell injury. To have an in For the ECM experiments, SMC were seeded at a
vivo-relevant positive control, SMC were mechanically density of 1.0·105 cells in 1% calf serum medium on
injured with a rubber policeman as described.12 For the prepared matrices. Following 24 hours of in-
preparation of conditioned media, both PDT and un- cubation at 37 °C, 10 lCi of L-[2,3,4,5-3H]-proline (23
treated cells were mechanically injured immediately Ci/mmol) or 5 lCi of L-[4,5-3H]-leucine (60 Ci/mmol)
following PDT-treatment. Using the MTT-assay, it was (Amersham, Arlington Heights, IL, U.S.A.) was added
shown that cell survival is reduced to less than 10% to the SMC for another 24 hours of incubation. For
in all groups after cell scraping (data not shown).11 the conditioned-media and PDGF experiments, the
The cells were then incubated for 24 hours to allow effector SMC were seeded on empty plates and, after
the cells to disintegrate and release biologically active 24 hours of incubation, the media was removed and
proteins. After this time, the medium was collected the prepared conditioned media or PDGF-solutions
and centrifuged at 2000 rpm to remove cellular debris were added together with [3H]-proline for 24 hours.
and the supernatant collected. In all collagen-production experiments, 50 lg/ml of
ascorbic acid was included in the medium.
After incubation, the medium was removed and the
cell layer washed 3 times with PBS. Subsequently,Collagen and protein production
0.5 N NaOH was added to dissolve the cells. The
collected material was precipitated with 20% tri-The production of collagen by SMC was evaluated by
chloroacetic acid (TCA) to remove the non-in-incorporation of [3H]-proline into an insoluble cell
corporated radioactive amino acids, and 1% BSA wasprotein, which is largely collagenous.13 For assessment
added as a carrier. The solution was allowed to floc-of total protein synthesis, [3H]-leucine incorporation
was determined. culate for 30 minutes and centrifuged at 14 000 rpm
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run in parallel and the cell number was analysed by
an electronic coulter counter after removal with 0.05%
trypsin.
Statistics
All data is expressed as mean–standard deviation
(s.d.). For comparison of means between multiple
groups, a one-way analysis of variance and Tukey’s
HSD post hoc test for multiple comparisons was applied
(Statistica, Statsoft, Tulsa, OK, U.S.A.). p-Values of less
than 0.05 were considered significant.
Fig. 2. Inhibition of SMC collagen production grown on PDT-treated
ECM. Collagen production, measured by [3H]-proline incorporation
into cell-associated proteins, by SMC seeded on untreated ECM and Results
compared to collagen production by SMC on ECM treated with
CASPc only (CASPc) or light only (light), PDT-treated ECM (PDT)
PDT effects on ECM-induction of SMC collagenand plates not covered by ECM (plate). Values are mean–s.d.
expressed as a percentage of baseline control (untreated ECM); production
*denotes p<0.0005 versus ECM, n=9 for ECM, n=6 for PDT and
CASPc only, and n=3 for light only and culture plate.
ECM deposited by EC in vitro is known to contain
numerous profibrotic factors, such as transforming
growth factor-b and PDGF.14,15 These experiments as-
sessed whether PDT of ECM could modify SMC pro-
duction of collagen. SMC seeded on ECM appeared
healthy and there were no morphologic differences
between cells grown on untreated ECM or PDT-treated
ECM (Fig. 1). However, it was previously dem-
onstrated that there is a slight decrease in cell at-
tachment after PDT of ECM.8 Therefore, the measured
radioactivity was corrected for the number of cells.
SMC grown on PDT-treated ECM demonstrated a
significant decrease (62.4–6.5%, p=0.0001) in [3H]-
proline incorporation as compared to untreated matrix
(100.0–7.5%). Laser irradiation only or drug exposure
only of the ECM did not have any effect (Fig. 2). As
Fig. 3. PDT inhibits SMC-injury-associated profibrotic response. The compared to untreated ECM, SMC grown on an empty
conditioned media of control non-treated (NT) SMC, mechanically plate also showed a decrease (p=0.0001) in [3H]-pro-
injured (INJ) SMC, and injured SMC that were PDT-treated with
line incorporation (Fig. 2).10 J/cm2 and 100 J/cm2, were used to assess its activity on SMC
production of collagenous proteins ([3H]-proline incorporation). Val- The decrease in collagen synthesis by SMC grown
ues are mean–s.d. expressed as a percentage of baseline NT control; on PDT-treated ECM did not appear to be specific for
* denotes p<0.0005 vs. NT, n=6 in all groups except n=9 in NT.
collagen since total protein synthesis (3H-leucine) was
similarly affected. As compared to total protein syn-
thesis by SMC grown on untreated matrix (100–4.9%)
for 30 minutes. Supernatant was then removed and there was a reduction to 59.1–6.6% (p=0.0002) by
5% TCA was added twice for washing. Finally, 1N SMC grown on PDT-treated matrix and to 67.1–2.6%
NaOH was incubated with the pellet for 24 hours at (p=0.0002) by SMC grown on an empty cell-culture
37 °C and an additional 3 hours at 60 °C to dissolve plate.
the protein material. The solution was supplemented
with 3.0 ml of liquid scintillation cocktail (Beckman
Instrument, Inc., Fullerton, CA, U.S.A.) and radio- Effect of PDT on injury-associated stimulation of collagen
productionactivity was determined with an automatic radioactive
counter Beckman #LS 3801). For the purpose of nor-
SMC are known to contain cytokines that are releasedmalising protein content to cell number, a group of
SMC treated similarly to the experimental group was upon cell injury. These experiments confirmed that
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Discussion
Restenosis develops as the result of an aberrant wound
healing process which involves an excessive fibro-
proliferative response associated with injury to the
vessel wall.2 Vascular PDT is a local experimental
approach to inhibit IH based on the acute depletion
of cells at the site of treatment. However, the ultimate
outcome of the vascular healing process following
injury and subsequent PDT is also dependent on the
biological behaviour of surviving vascular cells,
namely at the borders of the PDT-treatment field.
Proliferation and migration of SMC are early events
Fig. 4. PDT inhibits the profibrotic activity of PDGF. A solution of in the vascular injury response, but sustained pro-
PDGF (5 lg/ml) containing the photosensitiser CASPc (5 lg/ml) duction of connective tissue proteins by SMC in the
was directly irradiated with 675 nm light and incubated with SMC.
intima is responsible for the bulk of the intimal lesion.16Collagen production ([3H]-proline incorporation) of SMC incubated
with CASPc without PDGF served as baseline control and compared Although it is not clear why SMC continue to produce
with the CASPc-PDGF solution as positive control and PDT with excessive amounts of matrix proteins, it has been
10 and 100 J/cm2. Values are mean–s.d. expressed as a percentage
suggested that matrix-associated cytokines could be aof CASPc only control; * denotes p<0.005 vs. PDGF, n=6 for all
groups. source of long-term stimulation of SMC-matrix pro-
duction. Release of several factors, such as PDGF
and TGF-b, from adhering platelets and injured SMC
represent an important pathway for deposition of these
mechanically injured cells could induce a fibrotic re- bioactive molecules in the ECM.17,18 The present studysponse and that PDT could interfere with this process
was designed to examine whether PDT could interfere(Fig. 3). As compared to the conditioned media of
with these factors that regulate the fibrotic responseuntreated SMC, the conditioned media of mechani-
associated with vascular injury. An in vitro model wascally injured SMC caused a significant increase
used which enabled the evaluation of PDT effects on(168.5–27.6%,p=0.0004) incollagenproduction.Where-
separate elements involved in SMC production ofas PDT of SMC with 10 J/cm2 prior to mechanical
collagen and protein.injury did not affect (204.9–36.2%, p=0.0002 vs. un-
The findings show that, as compared to SMC seededtreated) this fibrotic response, PDT with 100 J/cm2
on empty cell-culture plates, there is a significantsignificantly reduced (124–24%, p=0.03 versus in-
increase in collagen and total protein production byjured SMC) the collagen production associated with
SMC seeded on EC-derived ECM. This increase inSMC injury and was similar to uninjured cells
collagen production is also noted when cells are in-(100.0–6.5%, p=0.26 vs. untreated).
cubated with the conditioned media of injured SMC.
These results confirm the presence of matrix and cell-
associated factors that stimulate SMC production of
collagen and other proteins. It is known from the
literature that matrix deposited by EC in culture con-Effect of PDT on PDGF-stimulation of collagen
tains many cell growth regulators, including PDGF,14production
TGF-b15 and basic fibroblast growth factor (bFGF).19 In
addition, SMC in culture are known to contain severalTo evaluate whether the decrease in collagen pro-
growth regulatory peptides and it has been shownduction of PDT-treated cell could be mediated by
that mechanical injury results in growth-factor re-inactivation of profibrotic factors, these experiments
lease.20 Some of these growth factors are also potentdirectly examined the effects of PDT on PDGF. PDGF-
profibrotic factors for different cell types includingmediated stimulation of SMC resulted in a significant
SMC. Both TGF-b and PDGF have been shown toincrease (181.2–19.8%, p=0.0002) in collagen pro-
stimulate matrix production in SMC and are believedduction versus control (100.0–3.9%). In a dose-de-
to play an important role in the fibrotic process afterpendent way, PDT of PDGF inhibited this profibrotic
vascular injury.21,22response. At 100 J/cm2, there was a significant decrease
The present data show that SMC grown on PDT-(124.3–13.7%, p=0.0002) in SMC collagen production
as compared to non-irradiated PDGF (Fig. 4). treated ECM results in a significant reduction in col-
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